Association of neurocognition with transition to psychosis: Baseline functioning in the second phase of the north American prodrome longitudinal study

JAMA Psychiatry

Volumn 73, Issue 12, 2016, Pages 1239-1248

  Seidman, Larry J ^a,b   Shapiro, Daniel I ^a   Stone, William S ^a   Woodberry, Kristen A ^a   Ronzio, Ashley ^a   Cornblatt, Barbara A ^c   Addington, Jean ^d   Bearden, Carrie E ^e   Cadenhead, Kristin S ^f   Cannon, Tyrone D ^g,h   Mathalon, Daniel H ^i,j   McGlashan, Thomas H ^h   Perkins, Diana O ^k   Tsuang, Ming T ^f   Walker, Elaine F ^l,m   Woods, Scott W ^h  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g YALE UNIVERSITY   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l EMORY UNIVERSITY   (United States)

^m EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION; CHILD; CONTROLLED STUDY; DECLARATIVE MEMORY; DEPTH PERCEPTION; DISORDERS OF HIGHER CEREBRAL FUNCTION; EFFECT SIZE; EXECUTIVE FUNCTION; FACTOR ANALYSIS; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NORTH AMERICAN; PERSECUTORY DELUSION; PSYCHOSIS; SUSPICIOUSNESS; THINKING; VERBAL BEHAVIOR; WORKING MEMORY; CASE CONTROL STUDY; CLINICAL TRIAL; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; NEUROCOGNITIVE DISORDERS; NORTH AMERICA; PREDICTIVE VALUE; PRODROMAL SYMPTOM; PSYCHOLOGY; PSYCHOTIC DISORDERS; REFERENCE VALUE; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROCOGNITIVE DISORDERS; NEUROPSYCHOLOGICAL TESTS; NORTH AMERICA; PREDICTIVE VALUE OF TESTS; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; REFERENCE VALUES; RISK; YOUNG ADULT;

EID: 85010293246     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2479     Document Type: Article

References (73)

1. Mirsky AF. Neuropsychological bases of schizophrenia. Annu Rev Psychol. 1969;20:321-348.
2. Seidman LJ. Schizophrenia and brain dysfunction: an integration of recent neurodiagnostic findings. Psychol Bull. 1983;94(2): 195-238.
3. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? AmJ Psychiatry. 1996;153(3):321-330.
4. Heinrichs RW. The primacy of cognition in schizophrenia. Am Psychol. 2005;60(3):229-242.
5. Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70(10):1107-1112.
6. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med. 2011;41(2):225-241.
7. Heckers S. What is the core of schizophrenia? JAMA Psychiatry. 2013;70(10):1009-1010.
8. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: E & S Livingston; 1919.
9. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York, NY: International Universities Press; 1950.
10. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: ameta-analytic review. Am J Psychiatry. 2008;165(5):579-587.
11. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study. Am J Psychiatry. 2010;167(2):160-169.
12. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59(5):449-456.
13. Fusar-Poli P, Deste G, Smieskova R, et al. Cognitive functioning in prodromal psychosis: ameta-analysis. Arch Gen Psychiatry. 2012;69(6): 562-571.
14. Giuliano AJ, Li H,Mesholam-Gately RI, Sorenson SM,Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: A quantitative and qualitative review. Curr Pharm Des. 2012;18(4):399-415.
15. Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014;40(4):744-755.
16. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: ameta-analytic review. Neuropsychology. 2009;23(3):315-336.
17. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology. 1998;12(3):426-445.
18. MacCabe JH, Wicks S, Löfving S, et al. Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: A Swedish longitudinal cohort study in males. JAMA Psychiatry. 2013;70(3):261-270.
19. Liu CH, KeshavanMS, Tronick E, Seidman LJ. Perinatal risks and childhood premorbid indicators of later psychosis: next steps for early psychosocial interventions. Schizophr Bull. 2015;41(4):801-816.
20. McGlashan TH,Walsh BC,Woods SW. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up. New York, NY: Oxford University Press Inc; 2010.
21. Lencz T, Smith CW, McLaughlin D, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2006;59 (9):863-871.
22. Seidman LJ, Giuliano AJ,Meyer EC, et al; North American Prodrome Longitudinal Study (NAPLS) Group. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010;67(6):578-588.
23. Frommann I, Pukrop R, Brinkmeyer J, et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early-and additional memory dysfunction in the late-prodromal state. Schizophr Bull. 2011;37 (4):861-873.
24. Michel C, Ruhrmann S, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F. A stratified model for psychosis prediction in clinical practice. Schizophr Bull. 2014;40(6):1533-1542.
25. Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull. 1984;10(2):160-203.
26. Cornblatt BA, Keilp JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull. 1994;20(1):31-46.
27. Park S, Holzman PS. Schizophrenics show spatialworking memory deficits. Arch Gen Psychiatry. 1992;49(12):975-982.
28. Park S, Gooding DC.Working memory impairment as an endophenotypic marker of a schizophrenia diathesis. Schizophr Res Cogn. 2014;1 (3):127-136.
29. Tamminga CA, Stan AD,Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry. 2010;167(10):1178-1193.
30. Saykin AJ, Shtasel DL, Gur RE, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51(2):124-131.
31. Aleman A, Hijman R, de Haan EHF, Kahn RS. Memory impairment in schizophrenia: ameta-analysis. Am J Psychiatry. 1999;156(9):1358-1366.
32. BrewerWJ,Wood SJ,McGorry PD, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry. 2003;160 (10):1790-1794.
33. Turetsky BI, Kamath V, Calkins ME, et al. Olfaction and schizophrenia clinical risk status: just the facts. Schizophr Res. 2012;139(1-3):260-261.
34. Dickinson D, RamseyME, Gold JM. Overlooking the obvious: ameta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64(5): 532-542.
35. Schaefer J, Giangrande E,Weinberger DR, Dickinson D. The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res. 2013;150(1):42-50.
36. Woodberry KA, Seidman LJ, Giuliano AJ, Verdi MB, Cook WL, McFarlane WR. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res. 2010;123(2-3):188-198.
37. Woods SW, Addington J, Bearden CE, et al. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013;148(1-3):99-104.
38. McGrath LM, Braaten EB, Doty ND, et al. Extending the "cross-disorder" relevance of executive functions to dimensional neuropsychiatric traits in youth. J Child Psychol Psychiatry. 2016;57(4):462-471.
39. Hill SK, Reilly JL, Keefe RSE, et al. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013; 170(11):1275-1284.
40. Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res. 2006;88(1-3):26-35.
41. Riecher-Rössler A, Pflueger MO, Aston J, et al. Efficacy of using cognitive status in predicting psychosis: A 7-year follow-up. Biol Psychiatry. 2009; 66(11):1023-1030.
42. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142(1-3):77-82.
43. Addington J, Liu L, Buchy L, et al. North American Prodrome Longitudinal Study (NAPLS 2): The prodromal symptoms. J Nerv Ment Dis. 2015; 203(5):328-335.
44. Spitzer RL, Williams JB, Gibbon M. Instruction Manual for the Structured Clinical Interview for DSMIV. New York: Biometrics Research Dept, New York State Psychiatric Institute; 1994.
45. Cannon TD, Yu C, Addington J, et al. An individualized risk calculator for research in prodromal psychosis [published online July 1, 2016]. Am J Psychiatry.
46. Drake RE, Mueser K, McHugo G. Clinical rating scales. In: Sederer L, Dickey B, eds. Outcomes Assessment in Clinical Practice. Baltimore, MD: Williams & Wilkins; 1996:113-116.
47. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: The Calgary Depression Scale. Br J Psychiatry Suppl. 1993;163 (22):39-44.
48. Addington J, Shah H, Liu L, Addington D. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophr Res. 2014;153(1-3): 64-67.
49. Nuechterlein KH, Green MF. MATRICS Consensus Cognitive Battery. Los Angeles, CA: MATRICS Assessment Inc; 2006.
50. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203-213.
51. Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165(2):214-220.
52. McCleery A, Green MF, Hellemann GS, et al. Latent structure of cognition in schizophrenia: A confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychol Med. 2015;45(12):2657-2666.
53. Wechsler D.WASI Manual. San Antonio, CA: Psychological Corp, Harcourt Brace & Co; 1999.
54. Wilkinson GS, Robertson GJ. The Wide Range Achievement Test Administration Manual. 4th ed. Wilmington, DE: Wide Range Inc; 2006.
55. Hoffman RE,Woods SW, Hawkins KA, et al. Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. Br J Psychiatry. 2007;191(4):355-356.
56. Doty RL. The Smell Identification Test TM Administration Manual. 3rd ed. Haddon Heights, NJ: Sensonics Inc; 1995.
57. Jacobson S, van Erp TG, Karlsgodt K, Torre J, Bearden CE, Cannon TD. Reduced temporo-limbic engagement during encoding of word pairs in an associative memory task in the psychosis prodrome: baseline fMRI findings from the North American Prodrome Longitudinal Study (NAPLS). Paper presented at: 13th International Congress on Schizophrenia Research (IC0SR); April 2-6, 2011; Colorado Springs, CO.
58. Seidman LJ, Breiter HC, Goodman JM, et al. A functional magnetic resonance imaging study of auditory vigilance with low and high information processing demands. Neuropsychology. 1998;12(4): 505-518.
59. Seidman LJ,Meyer EC, Giuliano AJ, et al. Auditory working memory impairments in individuals at familial high risk for schizophrenia. Neuropsychology. 2012;26(3):288-303.
60. Huang S, Seidman LJ, Rossi S, Ahveninen J. Distinct cortical networks activated by auditory attention and working memory load. Neuroimage. 2013;83:1098-1108.
61. Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: A data analyst's perspective. Multivariate Behav Res. 1998;33(4): 545-571.
62. Rubin DB. Multiple imputation after 18+ years. J AmStat Assoc. 1996;91:473-489.
63. SPSS [computer program]. Version 23.0. Armonk, NY: IBM Corp; 2014.
64. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28-37.
65. Seidman LJ. Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev. 2006;26(4):466-485.
66. Cirillo MA, Seidman LJ. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev. 2003;13(2):43-77.
67. Carrión RE, Cornblatt BA, Burton CZ, et al. Personalized prediction of psychosis: external validation of the NAPLS-2 psychosis risk calculator with the EDIPPP project [published online July 1, 2016]. Am J Psychiatry.
68. Gold JM, Barch DM, Carter CS, et al. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophr Bull. 2012;38 (1):144-152.
69. KeshavanMS, Vinogradov S, Rumsey J, Sherrill J,Wagner A. Cognitive training in mental disorders: update and future directions. Am J Psychiatry. 2014;171(5):510-522.
70. Rauchensteiner S, KawohlW, Ozgurdal S, et al. Test-performance after cognitive training in persons at risk mental state of schizophrenia and patients with schizophrenia. Psychiatry Res. 2011; 185(3):334-339.
71. Holzer L, Urben S, Passini CM, et al. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behav Cogn Psychother. 2014;42(4):421-434.
72. Hooker CI, Carol EE, Eisenstein TJ, et al. A pilot study of cognitive training in clinical high risk for psychosis: initial evidence of cognitive benefit. Schizophr Res. 2014;157(1-3):314-316.
73. Piskulic D, Barbato M, Liu L, Addington J. Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Res. 2015;225(1-2):93-98.